Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex.

J Med Genet

Cancer Genetics Laboratory, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Published: September 2022

Tuberous sclerosis complex (TSC) is a genetic syndrome due to mutations in either or , leading to the development of hamartomatous tumours at multiple body sites, including facial skin (facial angiofibroma (FAF)), brain (cortical tubers) and kidney (angiomyolipoma (AML)). In this report, we describe an individual with minimal TSC clinical features, who had 'no mutation identified' (NMI) by prior genetic testing in a clinical laboratory. Our massively parallel sequencing (MPS) analysis of multiple samples from different body sites and tumours (including blood, saliva, normal skin, AML and FAF) revealed an extraordinary situation in which FAF and AML had completely independent inactivating biallelic variants in not present in other matched samples. This suggests that the two different lesions (AML and FAF) are not due to the same underlying germline or mosaic mutation, rather both are likely sporadic events. This case demonstrates the relevance of thorough clinical examination, high-coverage MPS of multiple tumours and matched normal tissues, and appropriate genetic counselling for individuals with marginal TSC features and possible or mosaicism.

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2021-108160DOI Listing

Publication Analysis

Top Keywords

facial angiofibroma
8
tuberous sclerosis
8
sclerosis complex
8
body sites
8
aml faf
8
sporadic facial
4
angiofibroma sporadic
4
sporadic angiomyolipoma
4
angiomyolipoma mimicking
4
mimicking tuberous
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!